Immune checkpoint inhibitors (ICI) have had a dramatic effect on cancer outcomes with their use increasing as indications expand. Despite impressive efficacy across a range of tumour types, their role ...
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world evidence and long-term data reinforce VYVGART’s sustained ...
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world evidence and long-term data reinforce VYVGART’s sustained ...
Privigen (human immunoglobulin G) is a prescription drug used to treat certain immune system conditions. The drug comes as an intravenous (IV) infusion (an injection into a vein given over time).
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
Around 5,000 Americans are diagnosed with amyotrophic lateral sclerosis (ALS) each year. About half of patients die within 14 to 18 months of being diagnosed, usually due to breathing failure. The ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block ...
The advent of new biologic medicines in the past 25 years has been transformational, introducing powerful new treatments for a range of autoimmune disorders. But these drugs don’t help all patients ...
Having a robust enough immune system to live a longer life may come at the cost of chronic inflammation. Some immune cells undergo an inflammatory form of death that evolved to protect us from ...
Most people know there are two types of diabetes—type 1 and type 2. Knowing which one you have matters quite a lot for how you treat them. But what you may not know about is a lesser-known variation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback